<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for ONXX</title>
    <link />
    <description>Headlines for Onyx Pharmaceuticals, Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Will ASCO Unlock Big Value in This Cancer Drug Class?</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/18/will-asco-unlock-big-value-in-this-cancer-drug-cla/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 18 May 2013 14:30:00 GMT</pubDate>
    </item>
    <item>
      <title>Aveo Screwed Up but Its Kidney Cancer Drug Is Real</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11923962/1/aveo-screwed-up-but-its-kidney-cancer-drug-is-real.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Wed, 15 May 2013 09:24:00 GMT</pubDate>
    </item>
    <item>
      <title>Wider-than-Expected Loss at ChemoCentryx - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/99321/wider-than-expected-loss-at-chemocentryx.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Tue, 14 May 2013 09:55:01 GMT</pubDate>
    </item>
    <item>
      <title>3 Earnings Reports That Caught My Attention Last Week</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/13/3-earnings-reports-that-caught-my-attention-las-29/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 13 May 2013 08:52:00 GMT</pubDate>
    </item>
    <item>
      <title>Part 2: Will Array BioPharma Become A Late-Stage Biopharmaceutical Company?</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1428191-part-2-will-array-biopharma-become-a-late-stage-biopharmaceutical-company.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Sun, 12 May 2013 18:21:21 GMT</pubDate>
    </item>
    <item>
      <title>Good News for Cubist Pharmaceuticals  - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/99073/good-news-for-cubist-pharmaceuticals.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Thu, 09 May 2013 15:53:01 GMT</pubDate>
    </item>
    <item>
      <title>1 Casino, 1 Biotech And 1 Sofware Stock With Recent Intensive Insider Selling</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1419591-1-casino-1-biotech-and-1-sofware-stock-with-recent-intensive-insider-selling.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 09 May 2013 13:48:24 GMT</pubDate>
    </item>
    <item>
      <title>Narrower-than-Expected Loss at ArQule - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/99047/narrower-than-expected-loss-at-arqule.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Thu, 09 May 2013 13:05:01 GMT</pubDate>
    </item>
    <item>
      <title>Narrower Loss from Onyx, Guidance Maintained - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98967/narrower-loss-from-onyx-guidance-maintained.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Wed, 08 May 2013 17:32:01 GMT</pubDate>
    </item>
    <item>
      <title>Today's Stocks Driving Success For The Health Care Sector</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11917657/1/todays-stocks-driving-success-for-the-health-care-sector.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Wed, 08 May 2013 13:03:00 GMT</pubDate>
    </item>
    <item>
      <title>Onyx Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1412141-onyx-pharmaceuticals-management-discusses-q1-2013-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 07 May 2013 22:20:05 GMT</pubDate>
    </item>
    <item>
      <title>Pharmacyclics Inc. (PCYC): Today's Most Compelling Stock Buy</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/pharmacyclics-inc-pcyc-todays-most-compelling-stock-buy-cm244319.aspx?source=itxwebtxt0000015</link>
      <author>Nasdaq</author>
      <pubDate>Tue, 07 May 2013 13:53:41 GMT</pubDate>
    </item>
    <item>
      <title>Wider-than-Expected Loss at Corcept - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98841/wider-than-expected-loss-at-corcept.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Tue, 07 May 2013 11:40:01 GMT</pubDate>
    </item>
    <item>
      <title>Valeant Misses Earnings and Revenue Estimate in 1Q (Revised) - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98796/valeant-misses-earnings-and-revenue-estimate-in-1q-revised.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Tue, 07 May 2013 08:27:01 GMT</pubDate>
    </item>
    <item>
      <title>Positive Opinion on Allergan Candidate - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98760/positive-opinion-on-allergan-candidate.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Mon, 06 May 2013 16:30:01 GMT</pubDate>
    </item>
    <item>
      <title>Perrigo Likely to Report In Line Earnings - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98754/perrigo-likely-to-report-in-line-earnings.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Mon, 06 May 2013 15:30:01 GMT</pubDate>
    </item>
    <item>
      <title>Onyx Pharmaceuticals Inc. Stock Hold Recommendation Reiterated (ONXX)</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11914593/1/onyx-pharmaceuticals-inc-stock-hold-recommendation-reiterated-onxx.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Mon, 06 May 2013 10:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Tackling Cancer: Kidney Cancer's Biggest Current and Upcoming Players</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/05/tackling-cancer-kidney-cancers-biggest-current-upc/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sun, 05 May 2013 16:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Onyx Pharmaceuticals Inc. (ONXX): Today's Featured Health Care Laggard</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11913969/1/onyx-pharmaceuticals-inc-onxx-todays-featured-health-care-laggard.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Fri, 03 May 2013 17:01:00 GMT</pubDate>
    </item>
    <item>
      <title>Questcor Misses on Earnings, Revs  - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98629/questcor-misses-on-earnings-revs.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Fri, 03 May 2013 14:16:01 GMT</pubDate>
    </item>
  </channel>
</rss>
